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Abstract 
 
 
There is an urgent need for economical blood-based, noninvasive molecular biomarkers 
to assist in the detection and diagnosis of cancers in a cost-effective manner at an early 
stage, when curative interventions are still possible.  Serum autoantibodies are attractive 
biomarkers for early cancer detection, but their development has been hindered by the 
punctuated genetic nature of the ten million known cancer mutations.  A recent study of 
50,000 patients (Pedersen et al., 2013) showed p53 15-mer epitopes are much more 
sensitive colon cancer biomarkers than p53, which in turn is a more sensitive cancer 
biomarker than any other protein. The function of p53 as a nearly universal “tumor 
suppressor” is well established, because of its strong immunogenicity in terms of not 
only antibody recruitment, but also stimulation of autoantibodies. Here we examine 
bioinformatic fractal scaling analysis for identifying sensitive epitopes from the p53 
amino acid sequence, and show how it could be used for early cancer detection (ECD).  
We trim 15-mers to 7-mers, and identify specific 7-mers from other species that could 
be more sensitive to aggressive human cancers, such as liver cancer. 
 
1. Introduction In general protein-protein binding occurs at “hot spots” which are usually 
enriched in tryptophan, tyrosine and arginine, and hydrophobic occlusion of solvent is found to be 
a necessary condition for strong binding [1,2]. Interest in specific molecular biomarkers for early 
cancer detection is growing because of evidence that suggests that autoantibodies stimulated by 
cancer cells may share specific paratopes that selectively bind to p53 epitopes [3-7].   The 
superior selectivity of p53 epitopes for autoantibody paratopes [8] suggests that more specific 
mechanisms may be involved, such as interactions with paratope aromatic side chains and 
hydrophilic residues [2,9].  Among all proteins p53 is much more hydrophilic than average, and it 
is also elastically much softer, with about half its structure in its center dominated by β strands 
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[10,11], while the remainder (especially the N-terminal quarter) is disordered.  Because we are 
focused only on p53 and its epitopes, we are able to avoid the enormous complexity of millions of 
cancer genomic mutations [12]. Multiple signaling pathways, and/or multiple driver gene 
mutations, may be reflected simply in different p53 epitopic response patterns. 
 
The two bioinformatic scales reported here are the modern thermodynamically second order MZ 
hydropathicity scale, based on protein conformational self-organized criticality of 5000 protein 
segments [13,14], and the β strand exposed residue amino acid propensity scale, based on a 
survey of nearly 2000 β strand structures by FTI [15].  Parallel calculations carried out with the 
thermodynamically first order KD hydropathicity scale, based on water-air protein unfolding 
[16], and the FTI β strand buried residue amino acid propensity scale [15], gave weaker results 
and are not reported, except for one example.  
 
2. Materials and Methods How does p53 function as a universal tumor suppressor, the subject 
of nearly 10
5
 papers? It acts as transcriptional activator, controlling the expression of a variety of 
genes important in cell cycle regulation and apoptosis [17]. Normally conformational changes in 
globular proteins, either evolutionary or mutational in origin, are best described with hydropathic 
scales Ψ, with β strand propensity a secondary physico-chemical factor [18-20].  Because we are 
interested in epitopes with sizes between 7- and 15-mers, we display in Fig. 1 Ψ(n,9) and 
Ψ(n,13), where Ψ(n) is the MZ hydropathicity [13] of the nth amino acid in human p53, and 
superscale Ψ(n,W) is Ψ(n) averaged over a sliding window of wave length W.   
 
While Ψ(n) fluctuates rapidly with n, superscale Ψ(n,W) is smoothed and enables us to examine 
superscaled profiles.  As expected from earlier superscaled profiles of other proteins, including 
amyloids, superscaled profiles display several features important for protein folding and 
aggregation, including a DNA binding region hydrophobic plateau, and novel synchronized level 
elastic hinges [20] (see figure caption).  These long-range level double hinges are an example of 
evolutionary optimization of long-range interactions not included in most discussions of epitope-
paratope contact interactions [9].  The best value of W for superscaling depends on the property 
of interest, here the epitopes studied in [8]. 
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In Fig. 2 we compare the superscale profile of FTI β(n,9) with MZ ψ(n,9), and are pleasantly 
surprised.  The central DNA binding region 102-292 plateau, which already had abrupt edges in 
Fig. 1 for Ψ(n,9), has even more abrupt edges for β(n,9).  In this central region the correlation of 
β(n,9) and MZ ψ(n,9) is 0.51, while when the KD hydropathicity scale is used for Ψ(n,9), the 
correlation drops to 0.37.  Since the MZ and KD scales are 85% correlated [14], this shows that 
both MZ hydropathicity and exposed β strand propensity are central to p53 functionality.  We 
can go further and compare the positions of the centers of the nine highest peaks of β(n,9) with 
the centers of the crystal core β strands [11,12].  We find excellent agreement (within one or two 
sites) for eight peaks, while the ninth, at 171 near the protein center, is replaced by a stabilizing α 
helix (Table I). 
 
The tetramerization of p53 produces a flexible, four-armed starfish [17], quite distinct from the 
globular structures which most proteins (even when oligomerized) form.  Thus one should not be 
surprised by the improved description of p53 profiles with the exposed β strand propensity scale. 
 
The functionality of p53 as a tumor suppressor apparently depends on oligomer formation, such 
as tetramerization, which is driven by its core (DNA binding) domain and its tetramerization 
domain 325-356 near the C terminal [21,22].  At the physiological temperature of 37 degrees C, 
wild-type p53 is more than 50% unstructured [23].  Many studies have examined sequence-
dependent p53 oligomerization mechanisms similar to amyloid beta aggregation.  The most 
popular is the user-friendly TANGO software, which relies on the physico-chemical principles of 
β-sheet formation, extended by the assumption that the core regions of an aggregate are fully 
buried [24]. Using TANGO [24] found an epitopic β strand sequence 251-257, which is normally 
buried in the hydrophobic DNA binding domain (Fig. 1).  Mutations that would expose this 
conserved ILTIITL 7-mer would promote β sheet formation and disrupt oligomer formation. 
 
We compare our profiling results for the oligomerizing TANGO domain 251-257 with the MZ 
and FTI scales in Fig. 3.   
 
Profiles of the tetramerization domain for β(n,9) and Ψ(n,9), shown in Fig. 4, exhibit the greater 
resolution of the FTI β scale, and can be compared to the TANGO result in Fig. 3(b) of [24].  
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These results suggest an epitopic model for the anomalously universal p53 tumor suppressor 
mechanism.  Autoantibodies are recruited by p53 through real or virtual β strand epitope binding 
to antibody paratopes.  This binding is weak, but it may be identifiable by exploiting the 
economy of β(n,9) and Ψ(n,9) superscale profiles, with both showing sensitive binding peaks but 
the former showing enhanced structure.  This model can be tested against the epitopes identified 
by [8]. 
 
3.  Results  15-mer overlapping epitopes numbered XY, containing amino acids 5(10X +Y) – 4 
to 5(10X +Y) + 10, were winnowed by comparing patients with colon cancer to healthy controls, 
eventually reducing 78 starting epitopes to 11 sensitive candidate epitopes.  Of these, 4 were 
found to be ECD successes: 9,10,25,78.  These are profiled in Figs. 5-7.  In some cases one sees 
MZ ψ(n,9) hydrophobic peaks  that agree with the ECD successes, but not in other cases. In all 
cases there is an excellent match between the ECD successes and narrow β(n,9) peaks, usually 
only 7-mers.  The profiles show that overlapping 15-mer epitopes -9 and -10 were successful 
because they share a common 7-mer.  Comparison of Fig. 5(a) with Fig. 5(b) shows how much 
more useful the FTI βexp scale is compared to ψ hydropathicity scales. 
 
Generally one would not expect epitopes based on other species to be as sensitive (better peaks 
in β(n,9)) as human epitopes, and this is usually the case.  Mouse epitopes would be expected to 
be inferior, and this is the case for most of p53.   However, near the C terminal the mouse peaks 
are higher.  As shown in Fig. 8, this suggests an alternative choice for the -78 epitope, which 
could be more sensitive with a mouse sequence.  Similarly the dog sequence for the -25 epitope 
could be better than the human sequence (Fig. 6).  
 
The most notable and mysterious epitope is -34 (166-180), which dominates the sensitivity of the 
cancer surveys A and B of [8], but has below average sensitivity for ECD (C of [8], Fig. 1).  As 
we already noted, the ninth and missing β strand should have been centered at 172, but it has 
been replaced by residual α helices.  Because -34 is exceptional, its enlarged profiles are shown 
in Fig. 9, with a figure caption that may explain -34’s exceptional behavior. Also Fig. 10 
analyzes the marginally sensitive -43,-44,-45 cluster and suggests a possibly better choice of 
epitopes, which could achieve sensitivity comparable to -25 and -78. 
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The significance of virtual β strand epitopic binding is illustrated by the crystal structure of 
MDM2 binding to the transactivation domain 1-44 of p53 [26].  There have been >6000 studies 
of the strong and important p53-MDM2 interaction, with a view to inhibiting it to restore p53 
levels [27].  The segment of p53 bound to MDM2 in the structural study is a 15-mer, 15-29, with 
structure identified for 17-29 [26].  The corresponding profiles are shown in Fig. 11.  Although 
not directly useful for ECD, it is interesting that that the p53-MDM2 binding depends on large 
hydrogen bonding density, which is accurately recognized by FTI β transforms. 
 
4.  Discussion In several respects p53 can be described as a highly adaptive “scale free” hub in 
the self-organized cellular network [28,29], which supports the superior performance of the MZ 
Ψ scale compared to the KD Ψ scale.   Disruption of p53’s functions promotes most cancers.  
With respect to the new data of [8] for p53 epitopic binding to autoantibody paratopes, we have 
reached three main conclusions. 
(1) Epitope-paratope p53 interactions are dominated by both hydropathic Ψ forces and by 
hydrogen bonding and Van der Waals β strand forces.  Of the many proteins we have 
studied, the β effects are much larger for soft, starfish-shaped p53 tetramers than for 
typical rigid proteins like lysozyme c, where hydropathic ψ forces dominate [18], or 
compact tetrameric hemoglobin, which is nearly tetrahedral in shape.  The qualitative 
importance of hydrogen bonding and Van der Waals forces for lock-and-key binding was 
recognized by Pauling in the 1940s, and is stated qualitatively, for example, in the study 
of the Fv fragment of the antibody D1.3 in its complex with rigid hen egg white 
lysozyme [9,30].  The present analysis using Ψ and β scaling is quantitative, and 
represents a substantial refinement of cellular network models of p53 [27]. 
 
(2)  Our profiling p53 with hydropathic Ψ and β strand bioinformatic scales differs from 
hydrogen-bridged contact models [9] because it includes long range (W = 9) water 
network forces.  Our method is much simpler and probably more accurate for p53 
epitopes than methods based on all-atom force fields, where many geometrical details of 
paratope-epitope interactions are unknown.  It is advantageous for ECD because it is 
economical and its only adjustable sliding window (superscaled) W parameters have a 
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simple interpretation.  [8] used overlapping 15-mers because one supposes that epitope-
paratope binding is dominated by short sequences, which have here have been trimmed to 
be predominantly p53 7-mers.  In any case, while the studies of [8] were confined to ECD 
of colon cancers, there are many other cancers that could be studied using similar 
methods. Such studies could be made more economical with the present analysis.  It not 
only sharpens the definitions of 15-mer epitopes down to 7-mers, but it also shows (Fig. 
2) that the overall number of candidate epitopes is smaller than the winnowed results of 
[8] could have suggested. 
 
(3) An example of current practice is the study of liver cancer, which used a panel of 41 
recombinant tumor-associated antigen fragments (obtained by ELISA) to distinguish 
between healthy patients and patients with diagnosable tumors [31].  This panel was 
reduced to 10 antigens and was as effective (40% sensitivity, 20% false positives) as 
other diagnostic methods, such as ultrasound. One of the antigens was a large p53 
fragment, which has been shown to be much less sensitive than p53 epitopes for colon 
cancer [8].  It appears that aggressive cancers like liver cancer could be profitably studied 
with epitopic scanning of profiles from patients before and after surgery.  Instead of 
studying the emergence of cancer in a few patients in a large trial, one could study the 
reverse disappearance of tumor – specific autoantibodies after a successful resection.  In 
this case, the 50,000 patients of [8] could be replaced by 50 patients, with each patient’s 
loss of autoantibodies followed on a suitable time scale.  We suppose that this would be 
weeks, as aggressive cancers are expected to induce maximal effort to generate an 
immunological response to a severe stress, and absence of that stress could cause a rapid 
relaxation. 
 
(4)  It is instructive to compare the evolution of the numbers of papers on Web of Science on 
cancer and T cells with cancer and autoantibodies.  The former tripled from 2004 to 
2005, and since has increased by 50%. The latter number is about ten times smaller than 
the former in 2014, and has yet to break out.  The former has hit its stride, with 
impressive results for melanoma [32].  The problem of finding pathways between 10 
million cancer mutations [12,33] can be simplified by studying 6 million samples for 
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each of 21 tumor types [34].  By using p53 epitopes and studying reversed autoantibody 
dynamics in liver transplant patients, one can avoid million-fold genomic questions 
entirely.  The time may be ripe for developing p53 epitopes for early cancer screening for 
many cancers to break out [35].   
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βexp9 peak site         1TUP β strand 
123                                  123-127 
143                                  141-147 
159                                   156-163 
172                                   helix 
199                                   195-198 
214                                    214-219 
233                                    230-237 
252                                    251-259 
271                                     264-271 
Table I  Comparison of positions of βexp9 peak sites with β strands observed in a 96-308 p53 
fragment complexed with DNA  [10]. The peaks agree well with the strands, and are usually near 
the centers of the strands.         
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Figure Legends 
  
Fig. 1.  The hydroprofiles Ψ(n,W), with W = 9 and 13 exhibit abrupt edges for the 102-292 DNA 
binding domain of p53 [11].  The double arrows I and II are two deepest level (doubled) 
hydrophilic extrema for W = 9 which can synchronize mechanically for conformational changes.  
The synchronization principles underlying level sets are discussed in [20].  Briefly, protein 
conformational changes occur over long times of order μs to ms, and involve relative motions of 
the weakly interacting water-protein interface extrema over allometric (long) distances along the 
protein chain (for I here, about 60 aa, which is  >> W ~ 9-13).  The oligomer-forming 
(tetramerization) domain 325-356 also has nearly level sharp edges, which should facilitate 
oligomer formation.  The green dashes mark the hydroneutral average for the Ψ(n,W) scales used 
here.  Above the green lines is hydrophobic, and below is hydrophilic. The leading biomarker 
epitopes of [8] are also indicated. 
 
Fig. 2.  Profiles of p53 using the FTI βex Ψ scale peak more strongly than the hydropathicity MZ 
Ψ scale for the DNA binding [11] and tetramerization [21] domains, and the remaining peaks of 
the DNA BD also match the β strands found in the crystal [11], see text and Table I.  The FTI 
scale values [15] have been multiplied by 150 to display them in the same range as the MZ scale 
from [14]. 
 
Fig. 3.  The key oligomerizing ILTIITL 7-mer, 251-257 [24], appears as twice a stronger peak 
with the β strand propensity FTI scale than with the MZ scale.  These profiles are shown at high 
resolution with W = 5.  This figure can be compared to the TANGO result shown in Suppl. Fig. 
3(b) of [24].  The relatively larger success of the FTI scale in finding the ILTIITL 7-mer is based 
on Ile, which has the second-largest value of β strand propensity on the FTI scale.  
 
Fig. 4.  The tetramerization domain 325-356 has a composite β – α structure [21].  Here W = 9 
has been used to clarify the α - β separation, which is clearer with the β strand propensity scale. 
 
Fig. 5(a).  Profiles for four scales in the key -9-10 region 41-60, with W = 5.  The choice of a 
small W produces noisy profiles, but the success of the βex scale compared to the other scales in 
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identifying the central 7-mer 50-56 IEQWFTE epitope is clear (double arrow).  Note the Trp53 = 
W53 at the center of this epitope, and how use of the βex scale lifts the 50-56 compressed 
epitope well above noise level. 
 
Fig. 5(b).  Here we have chosen W = 9, in order to reduce noise, and only the two best scales are 
displayed for clarity. The two best-performing epitopes, -9, -10, are associated with a single 7-
mer 49-55, DIEQWFT, which is common to -9 and -10 (red double arrow).   The lean goat (high 
fiber diet) 7-mer EDVVTWL is the only epitope studied that gives a higher peak (two V’s, 
largest FTI βexp) than DIEQWFT, and it should be tested. 
 
Fig. 6.  The -25 epitope contains the 120-126 7-mer KSVTCTY with a βexp peak value of 206 at 
site 123.  It appears that this 7-mer would also produce a signal for -24, but none was seen [4].   
However, at 120 there are both a hydrophilic minimum (elastic hinge) and a turn in the p53 core 
structure bound to DNA [11].  Thus -24 would not fit stably to an antibody paratope.  The 
corresponding dog sequence is KSVTWTY, which could be better, as βexp(W124) > 
βexp(C124).  
 
Fig. 7.   The -78 epitope, a 381-393 (p53 end) 13-mer, could have been more sensitive had it 
contained the 377-387 mer TSRHKKLMFKT.  Because of proximity to the 393 end, W = 7 has 
been used here.  The monkey sequence TSRHKKFMFKT might be better, as βexp(F383) > 
βexp(L383). 
 
Fig. 8.  Comparison of human and mouse  W = 7 profiles (human numbering) near C terminal.  It 
is possible that an epitope centered on 379Val (mouse numbering), such as the 7-mer 
376KTMVKKV382 (red double arrow) could be a better epitopic probe than the 7-mer human 
epitope (blue double arrow) also shown in Fig. 7. 
 
Fig. 9.  The -34 epitope contains the 169-176 8-mer MTEVVRRC with a peak value of Ψβex9 = 
227 at site 172.  Comparison with Figs. 2 and 6 shows that epitope -34 has twice as large a drop 
of βex9 between 172 and 187 as epitope -25 has between 123 and 131.  Initially the 
immunogenic interactions may be weaker and longer ranged and include this larger drop, so that 
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-34 does not form β strand bonds to antibody paratopes, whereas -25 does.  At later cancer 
stages, the interactions could be stronger and shorter ranged, when -34, with its 8-mer edges at 
Ψβex9 = 200, would produce a much stronger signal than -25, with its 7-mer edges at Ψβex9 = 
175. 
 
Fig. 10.  -43 to-45, shown here by three double arrows, were marginally sensitive [4].  These 
three 15-mers included two deep minima in β strand propensity.  It is possible that a shorter 7-
mer epitope, such as 213-219, would have been as successful as the four selected 15-mer 
epitopes 9,10,25 and 78. 
 
Fig. 11.  The structure of 15-29 (double blue arrow) a 15-mer epitope of p53 bound to a 109-
residue fragment of MDM2, was studied in [27], where a short induced helical segment 19-23 
(double red arrow) was found.  Note that the as-grown 15-mer epitope of p53 matches the peak 
in virtual β strand propensity very well, suggesting that the p53-MDM2 binding depends on large 
hydrogen bonding density.  For the MZ profile we used W = 3, even though this gives large 
oscillations, because the induced helical segment is short.  Note that the ends of both double 
arrows are nearly level, and are examples of the “level set” principle [20]. 
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Fig. 8. 
 
 
Fig. 9 
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Fig. 10 
 
 
Fig. 11. 
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